Carcinoma of liver and intrahepatic biliary tract
MONDO:0018531A carcinoma that arises from the hepatocytes or intrahepatic bile ducts. The main subtypes are hepatocellular carcinoma (hepatoma) and cholangiocarcinoma.
Also known as: cancer of liver, cancer of liver and intrahepatic biliary tract, cancer of the liver, cancer of the liver and intrahepatic biliary tract, carcinoma of liver, hepatic cancer, liver and intrahepatic bile duct cancer, liver cancer
4255 clinical trials for this condition and its sub-types, 36 tagged with Carcinoma of liver and intrahepatic biliary tract itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Carcinoma of liver and intrahepatic biliary tract
-
Hepatocellular carcinoma 1,046 trials · 1,091 incl. sub-types
8 sub-types
- Hepatoblastoma 42 trials Sub-types →
- Pediatric hepatocellular carcinoma 36 trials
- Fibrolamellar hepatocellular carcinoma 15 trials Sub-types →
- Adult hepatocellular carcinoma 12 trials
- Aflatoxin-related hepatocellular carcinoma 0 trials
- Hepatocellular clear cell carcinoma 0 trials
- Liver diffuse large B-cell lymphoma 0 trials
- Sclerosing hepatic carcinoma 0 trials
-
Bile duct carcinoma 20 trials · 454 incl. sub-types
4 sub-types
- Extrahepatic bile duct carcinoma 51 trials · 432 incl. sub-types Sub-types →
- Bile duct adenocarcinoma 17 trials · 419 incl. sub-types Sub-types →
- Bile duct carcinoma in situ 0 trials Sub-types →
- Squamous cell bile duct carcinoma 0 trials Sub-types →
-
Liver neuroendocrine carcinoma 3 trials
2 sub-types
-
Biliary cystadenocarcinoma 0 trials
-
Liver carcinoma in situ 0 trials
1 sub-type
- Bile duct carcinoma in situ 0 trials Sub-types →
-
2 sub-types
- Liver adenosquamous carcinoma 0 trials Sub-types →
- Squamous cell bile duct carcinoma 0 trials Sub-types →
Most studied deeper sub-types
-
New chemo combo targets Hard-to-Treat liver cancer
Disease control Stopped earlyThis early-phase trial tested a two-step chemotherapy approach for people with a type of liver cancer (intrahepatic cholangiocarcinoma) that cannot be surgically removed. First, patients received a standard chemo mix (mFOLFIRINOX) through the veins. Then, they got a second chemo …
Phase 2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Experimental liver cancer drug shows promise in early trial
Disease control Stopped earlyThis phase 2 trial tested a drug called Taxoprexin (DHA-paclitaxel) in 13 people with advanced liver cancer that had not responded to prior treatments. The goal was to see if the drug could shrink tumors and how safe it was. The study was terminated early, so results are limited.
Phase 2 • Sponsor: American Regent, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New registry aims to sharpen liver tumor ablation techniques
Knowledge-focused Stopped earlyThis study tracked over 1,200 people with liver cancer who received microwave ablation, a procedure that uses heat to destroy tumors. Researchers collected data over 5 years to see how well the ablation worked and how long patients lived. The goal was to create better guidelines …
Sponsor: Ethicon, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC